{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/GDTC/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-08T19:33:54.700Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":12249,"canonical_name":"CytoMed Therapeutics Ltd","cik":"0001873093","uei":null,"lei":null,"duns":null,"ticker":"GDTC"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":14},"count":14,"timeline":[{"ts":"2026-08-11","kind":"sec.form144","reporter":"mDR Ltd","title":"10% Stockholder","shares":117337,"usd_value":103257,"security_title":"Ordinary Shares","approx_sale_date":"2026-08-11","accession_number":"0001477932-26-004854","importance":40.020651312},{"ts":"2026-08-11","kind":"sec.filing","form_type":"144","title":"144 — CytoMed Therapeutics Ltd — 2026-08-11","url_slug":"/sec/cik-0001873093/144/0001477932-26-004854","accession_number":"0001477932-26-004854","importance":30},{"ts":"2026-06-23","kind":"sec.filing","form_type":"6-K","title":"6-K — CytoMed Therapeutics Ltd — 2026-06-23","url_slug":"/sec/cik-0001873093/6-k/0001493152-26-029736","accession_number":"0001493152-26-029736","importance":30},{"ts":"2026-06-15","kind":"sec.filing","form_type":"4","title":"4 — CytoMed Therapeutics Ltd — 2026-06-15","url_slug":"/sec/cik-0001873093/4/0001493152-26-028589","accession_number":"0001493152-26-028589","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"6-K","title":"6-K — CytoMed Therapeutics Ltd — 2026-06-03","url_slug":"/sec/cik-0001873093/6-k/0001493152-26-027044","accession_number":"0001493152-26-027044","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"3","title":"3 — CytoMed Therapeutics Ltd — 2026-05-15","url_slug":"/sec/cik-0001873093/3/0001493152-26-023399","accession_number":"0001493152-26-023399","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"3","title":"3 — CytoMed Therapeutics Ltd — 2026-05-15","url_slug":"/sec/cik-0001873093/3/0001493152-26-023400","accession_number":"0001493152-26-023400","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"3","title":"3 — CytoMed Therapeutics Ltd — 2026-05-15","url_slug":"/sec/cik-0001873093/3/0001493152-26-023401","accession_number":"0001493152-26-023401","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"3","title":"3 — CytoMed Therapeutics Ltd — 2026-05-15","url_slug":"/sec/cik-0001873093/3/0001493152-26-023404","accession_number":"0001493152-26-023404","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"3","title":"3 — CytoMed Therapeutics Ltd — 2026-05-15","url_slug":"/sec/cik-0001873093/3/0001493152-26-023405","accession_number":"0001493152-26-023405","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"6-K","title":"6-K — CytoMed Therapeutics Ltd — 2026-05-15","url_slug":"/sec/cik-0001873093/6-k/0001493152-26-023342","accession_number":"0001493152-26-023342","importance":30},{"ts":"2026-05-13","kind":"sec.insider.p","reporter":"Choo Chee Kong","title":"","shares":112000,"price_per_share":1.1498,"usd_value":128778,"security_title":"Ordinary Shares, no par value per share","importance":50.1287776},{"ts":"2026-05-13","kind":"sec.form144","reporter":"mDR LTD","title":"10% Stockholder","shares":117337,"usd_value":98094,"security_title":"Ordinary Shares","approx_sale_date":"2026-05-13","accession_number":"0001477932-26-003023","importance":40.019618746},{"ts":"2026-05-13","kind":"sec.filing","form_type":"144","title":"144 — CytoMed Therapeutics Ltd — 2026-05-13","url_slug":"/sec/cik-0001873093/144/0001477932-26-003023","accession_number":"0001477932-26-003023","importance":30}]}